Targeted Hip Strength Training in Children With Cerebral Palsy (CP)
|ClinicalTrials.gov Identifier: NCT01633736|
Recruitment Status : Unknown
Verified July 2012 by University of Nottingham.
Recruitment status was: Recruiting
First Posted : July 4, 2012
Last Update Posted : July 4, 2012
|Condition or disease||Intervention/treatment||Phase|
|Cerebral Palsy||Other: Usual care plus progresive resistance training||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Targeted Hip Progressive Resistance Training to Improve Single Leg Balance and Walking in Children With Cerebral Palsy|
|Study Start Date :||December 2011|
|Estimated Primary Completion Date :||March 2013|
|Estimated Study Completion Date :||March 2013|
|Experimental: home progressive resistance exercise||
Other: Usual care plus progresive resistance training
Duration 8 weeks; two weeks of familiarisation with the intervention protocol without resistance (for familiarisation and neural adaptation) followed by 6 weeks progressive resistance (PR). The three times a week PR training will be as a home exercise program with fortnightly home visits to monitor/progress PR training. It comprises a 4 minute warm up and cool down with one exercise targeting the hip abductors and one the lateral rotators. Exercise prescription will follow existing guidelines for progressive PR training. Parents will be taught supervision by the researcher using clear explanations in words and pictures in a logbook. Logbooks have been found to facilitate compliance, dosage and motivation.
Other Name: strength training
- Gait parameter [ Time Frame: baseline, plus 8 weeks and plus 8 weeks (exit point) ]4 camera CODA gait analysis system for change in percentage stance phase of gait and stride in cm.
- Gross Motor Function Measure (GMFM) [ Time Frame: Baseline, plus 8 weeks and plus 8 weeks (exit) ]To investigate any change in dimensions D and E of fucntioal activity with standardised GMFM.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01633736
|Contact: Sarah E Westwater-Wood, MMedSci, BSc||+44 115 email@example.com|
|Contact: Grahame Pope, MPhil, BSc||+44 115 firstname.lastname@example.org|
|Divison of Physiotherapy, School of Nursing, Midwifery and Physiotherapy, The University of Nottingham||Recruiting|
|Nottingham, Nottinghamshire, United Kingdom, NG5 1PB|
|Contact: Grahame Pope email@example.com|
|Principal Investigator: Sarah E Westwater-Wood|
|Principal Investigator:||Grahame Pope, MPhil, BSc||The University of Nottingham|